# A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity

> **NCT03361774** · PHASE2 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Dentin Sensitivity

## Interventions

- **DRUG:** Dentifrice containing 5% w/w KNO3 and 0.454% w/w SnF2 (1100 ppm fluoride).
- **DRUG:** Dentifrice containing 0.454% w/w SnF2 (1100 ppm fluoride).

## Key facts

- **NCT ID:** NCT03361774
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-01
- **Primary completion:** 2018-12-03
- **Final completion:** 2018-12-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Cancelled before Active
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03361774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03361774, "A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03361774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*